EMCURE PHARMACEUTICALS LTD.

NSE : EMCUREBSE : 544210ISIN CODE : INE168P01015Industry : Pharmaceuticals & DrugsHouse : Private
BSE1640.1530.1 (+1.87 %)
PREV CLOSE (Rs.) 1610.05
OPEN PRICE (Rs.) 1640.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 20173
TODAY'S LOW / HIGH (Rs.)1620.00 1677.85
52 WK LOW / HIGH (Rs.)950 1688
NSE1637.2036.2 (+2.26 %)
PREV CLOSE( Rs. ) 1601.00
OPEN PRICE (Rs.) 1644.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1637.20 (66)
VOLUME 460196
TODAY'S LOW / HIGH(Rs.) 1595.10 1678.90
52 WK LOW / HIGH (Rs.)983 1688
Type
Select year
(Rs.in Million)
Particulars
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Profit Before Tax
9713.49
7272.28
7472.15
9725.48
6573.27
Adjustment
5515.12
5431.47
4923.49
3987.42
5820.95
Changes In working Capital
-4242.98
505.17
-2922.35
-2919.06
-3345.54
Cash Flow after changes in Working Capital
10985.63
13208.92
9473.29
10793.84
9048.68
Cash Flow from Operating Activities
8517.05
10972.40
7468.53
7682.07
7044.35
Cash Flow from Investing Activities
-940.01
-7125.12
-4676.85
-7887.91
-2518.48
Cash Flow from Financing Activities
-8139.57
-1642.06
-1453.97
-1518.51
-1889.04
Net Cash Inflow / Outflow
-562.53
2205.22
1337.71
-1724.35
2636.83
Opening Cash & Cash Equivalents
439.91
-1745.29
-3081.72
-3500.42
-6091.08
Cash & Cash Equivalent on Amalgamation / Take over / Merger
NA
NA
NA
2141.19
NA
Cash & Cash Equivalent of Subsidiaries under liquidations
NA
NA
NA
NA
NA
Translation adjustment on reserves / op cash balalces frgn subsidiaries
NA
NA
NA
NA
NA
Effect of Foreign Exchange Fluctuations
-20.49
-20.02
-1.28
1.86
-46.17
Closing Cash & Cash Equivalent
-143.11
439.91
-1745.29
-3081.72
-3500.42
CLOSE X

Filling complaints on SCORES Easy & quick

  • > Register on SCORES portal
  • > Mandatory details for filling complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances